Ginkgo Bioworks Holdings, Inc. (DNA) vs Verastem, Inc. (VSTM)
- Ginkgo Bioworks Holdings, Inc. DNA 10.27 −12.67%
- Verastem, Inc. VSTM 8.65 −6.28%
Ginkgo Bioworks Holdings, Inc. and Verastem, Inc. are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and Verastem, Inc. are of similar size ($835.9M and $791.9M). Verastem, Inc. grew revenue faster over the last twelve months: 472.9% against −37.0%. Ginkgo Bioworks Holdings, Inc. has the higher net margin (−219.6% vs −231.6%) and the lower return on invested capital (−161.9% vs 0.00%). Across the 18 metrics below, Ginkgo Bioworks Holdings, Inc. leads on 11 and Verastem, Inc. on 7.
Valuation
Profitability
| Metric | DNA | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 68.04% | 86.35% | 65.16% |
| Operating margin | (231.13%) | (182.57%) | 0.00% |
| Net margin | (219.60%) | (231.59%) | 0.00% |
| Free cash flow margin | (131.57%) | (185.31%) | 0.00% |
| Return on equity | (56.29%) | (471.16%) | (56.36%) |
| Return on assets | (26.19%) | (100.65%) | (48.04%) |
| Return on invested capital | (161.94%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack